Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1998
11/03/1998US5830507 Biotherapeutic cell-coated microspheres
11/03/1998US5830504 Cooperative combinations of ligands contained within a matrix
11/03/1998US5830492 Matrix containing a hormone encapsulated with polymer
11/03/1998US5830489 Protein preparation for the prevention and therapy of periodontitis
11/03/1998US5830475 Recombinant mycobacterial vaccines
11/03/1998US5830471 Methods and compositions comprising anti-lam-1 antibodies
11/03/1998US5830470 Humanized antibodies to ganglioside GM2
11/03/1998US5830469 Novel monoclonal antibodies that specifically bind to the extracellular domain of human fas antigen (aka: apo-1) for the treatment of diseases related to excess unwanted programmed or activation-induced cell death.
11/03/1998US5830468 Fibrin(ogen) degradation by fibrinolytic matrix metalloproteinase
11/03/1998US5830467 Pharmaceutical preparation containing protein C and a thrombolytically active substance
11/03/1998US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998US5830463 Yeast-based delivery vehicles
11/03/1998US5830462 Regulated transcription of targeted genes and other biological events
11/03/1998US5830461 Methods for promoting wound healing and treating transplant-associated vasculopathy
11/03/1998US5830458 Method for destroying a diseased human cell
11/03/1998US5830456 Treatment of viral disease with oral interferon-α
11/03/1998US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
11/03/1998US5830454 Mouse models of human disease
11/03/1998US5830453 Use of IL-13 to induce 15-lipoxygenase
11/03/1998US5830452 Method for enhancing the anti-tumor therapeutic index of interleukin-2
11/03/1998US5830451 Diagnosis of pregnancy, modulation of immune system to prevent spontaneous abortion, reduce graft verses host
11/03/1998US5830450 Compositions of leptin bound to an apolipoprotein
11/03/1998US5830448 Compositions and methods for the treatment of tumors
11/03/1998US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
11/03/1998US5830434 Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide
11/03/1998US5830430 Cationic lipids and the use thereof
11/03/1998CA2058443C Treating disorders by application of insulin-like growth factors and analogs
11/03/1998CA1340112C Supression of cell proliferation by decorin
11/03/1998CA1340111C Vectors and compounds for expression of zymogen forms of human protein c
11/03/1998CA1340110C Carcinoma-associated antigens, and antibodies which recognize these antigens
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998WO1998048025A2 Regulatory system for inducible expression of genes with lambdoid promoters
10/29/1998WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998WO1998048021A1 Kaposi's sarcoma herpesvirus (hhv8) protease and assembly protein
10/29/1998WO1998048018A1 Recombinant human beta interferon with enhanced solubility
10/29/1998WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998WO1998048016A1 Edg-1-like receptor
10/29/1998WO1998048015A1 Transcriptional regulator
10/29/1998WO1998048014A1 Cancer marker
10/29/1998WO1998048013A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998WO1998048012A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998WO1998048011A1 Novel chimeric molecules
10/29/1998WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998WO1998048002A1 Use of nerve growth factor for the storage, culture or treatment of cornea
10/29/1998WO1998047921A1 Mammalian cytokines; related reagents and methods
10/29/1998WO1998047919A1 Materials and methods relating to stabilising substances in cells
10/29/1998WO1998047918A1 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/29/1998WO1998047917A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
10/29/1998WO1998047915A1 Neoglycoproteins
10/29/1998WO1998047914A2 Us6 gene from the human cytomegalovirus (hcmv)
10/29/1998WO1998047913A2 Inhibition of hiv-1 replication by a tat rna-binding domain peptide analog
10/29/1998WO1998047911A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998WO1998047906A1 Phosphonic acid derivatives
10/29/1998WO1998047876A1 Heterocyclic derivatives and their use as antithrombotic agents
10/29/1998WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives
10/29/1998WO1998047531A2 Fc receptor non-binding anti-cd3 monoclonal antibodies deliver a partial tcr signal and induce clonal anergy
10/29/1998WO1998047529A1 Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
10/29/1998WO1998047528A1 Method of treating hypertension using a composition containing a dried animal stomach mucosa and endogenous protease-inhibitor peptides
10/29/1998WO1998047527A1 Compositions and methods comprising glycogenin-2
10/29/1998WO1998047526A1 Inhibin modulation of cell growth
10/29/1998WO1998047525A1 MATERIALS AND METHODS RELATING TO INHIBITING THE INTERACTION OF p53 AND mdm2
10/29/1998WO1998047524A1 Gastrin receptor-avid peptide conjugates
10/29/1998WO1998047523A1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
10/29/1998WO1998047522A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998WO1998047520A1 Prevention and treatment of allergic disease by targeted development of protective t-helper lymphocyte immunity
10/29/1998WO1998047519A1 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes
10/29/1998WO1998047497A2 Methods and compositions for the prevention and treatment of immunological disorders, inflammatory diseases and infections
10/29/1998WO1998047490A1 Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
10/29/1998WO1998047489A1 Sustained-release compositions and method for preparing same
10/29/1998WO1998047480A2 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium
10/29/1998WO1998047361A1 Treatment for diabetes
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998WO1998035045A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/29/1998WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998028332A3 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof
10/29/1998WO1998027205A3 Secreted proteins and polynucleotides encoding them
10/29/1998WO1998025643A3 Neuropeptides as modulators for cell differentiation and proliferation
10/29/1998WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998WO1998021233A3 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
10/29/1998WO1998017805A3 Invasion associated genes from neisseria meningitidis serogroup b
10/29/1998DE19748688A1 Membransystem zur gesteuerten Geweberegeneration bei Erkrankungen des Zahnhalteapparates Membrane system for guided tissue regeneration in diseases of the gums
10/29/1998DE19717864A1 Humanes rekombinantes Interferon-beta mit verbesserter Löslichkeit Human recombinant interferon-beta with improved solubility
10/29/1998CA2288649A1 Stable pharmaceutical administration forms of peptides, proteins and nucleic acids
10/29/1998CA2288335A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998CA2288292A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents
10/29/1998CA2288227A1 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
10/29/1998CA2288027A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
1 ... 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 ... 3163